I'm sure there are. Have at it.
If you find that at one point, they hoped to put IHL-216a through Phase 1 in the next 2 years, congratulations: welcome to biotech startup land. Timelines slip - it is to be expected. Furthermore, they probably STILL hope to initiate a Phase 1 trial for that asset in the next 2 years. They simply can't do it right this minute.
I'm not sure you should be investing in biotech startups if any of this is surprising to you.
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-17565
-
- There are more pages in this discussion • 2,621 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online